Journal of Adolescent and Family Health
Volume 6

Issue 1

Article 5

January 2014

Is hyperbaric oxygen therapy an effective treatment for autism? A
review
Daniel Dunleavy
Florida State University, Bthyer@mailer.fsu.edu

Bruce A. Thyer
Florida State University, Bthyer@fsu.edu

Follow this and additional works at: https://scholar.utc.edu/jafh
Part of the Alternative and Complementary Medicine Commons, Applied Behavior Analysis Commons,
Behavioral Disciplines and Activities Commons, Child Psychology Commons, Clinical and Medical Social
Work Commons, Disability and Equity in Education Commons, Mental Disorders Commons, Physical
Sciences and Mathematics Commons, Psychiatric and Mental Health Commons, and the Social Work
Commons

Recommended Citation
Dunleavy, Daniel and Thyer, Bruce A. (2014) "Is hyperbaric oxygen therapy an effective treatment for
autism? A review," Journal of Adolescent and Family Health: Vol. 6 : Iss. 1 , Article 5.
Available at: https://scholar.utc.edu/jafh/vol6/iss1/5

This articles is brought to you for free and open access by the Journals, Magazines, and Newsletters at UTC
Scholar. It has been accepted for inclusion in Journal of Adolescent and Family Health by an authorized editor of
UTC Scholar. For more information, please contact scholar@utc.edu.

Dunleavy and Thyer: HBOT for Autism
Running Head: IS HYPERBARIC OXYGEN THERAPY AN EFFECTIVE TREATMENT FOR AUTISM?

1

Is Hyperbaric Oxygen Therapy an Effective Treatment for Autism? A Review

Published by UTC Scholar, 2014

1

Journal of Adolescent and Family Health, Vol. 6 [2014], Iss. 1, Art. 5
IS HYPERBARIC OXYGEN THERAPY AN EFFECTIVE TREATMENT FOR AUTISM?

2

Abstract
Objectives: We review outcome studies regarding the effectiveness of hyperbaric oxygen
therapy (HBOT) for Autism Spectrum Disorders (ASD). Method: Studies were identified
through electronic bibliographic databases and manual searches of article reference lists.
Results: A total of 8 studies met eligibility criteria, consisting of three randomized controlled
trials (RCTs), one quasi-experimental study involving a comparison group, two pre-experimental
one-group pretest–posttest studies, and two single-system designs. Studies reviewed did not offer
credible evidence to suggest that HBOT is an effective treatment for autism. Conclusion: It is
premature to call HBOT an effective treatment for Autism and ASD. Individuals clinically
treated with HBOT outside the context of a RCT should have the effects of the therapy evaluated
using rigorous single-subject designs.

Keywords: Autism, Autism Spectrum Disorders, Autism Treatment, Hyperbaric Oxygen
Therapy, HBOT
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Is Hyperbaric Oxygen Therapy an Effective Treatment for Autism? A Review

Autism Spectrum Disorder (ASD) is a diagnostic label used to categorize individuals
with persistent deficits in social communication and interaction and also with various forms of
restricted and repetitive behavior (APA, American Psychiatric Association, 2013, pp. 50-59).
Specific examples of these behaviors include the failure of back and forth communication,
abnormal eye contact, a lack of facial expression, and an absence of interest in peers, among
others. The prevalence of ASD remains constant and may even be rising, effecting an estimated
1% of the population (APA, 2013, p. 55). Males have been shown to be diagnosed with ASD
more frequently than females, at a rate of 4.2:1 (Fombonne, 2009).
The etiology of autism remains unclear. Some have suggested a strong genetic
component exists (Trottier, Srivastava, & Walker, 1999), but a definitive link to the disorder’s
development has not been established clinically or etiologically (Miles, 2011). Proponents of this
view have relied primarily on research utilizing twin and family studies and/or molecular
genetics, but these methods have been plagued by problematic assumptions (e.g. the equalenvironment assumption) and a lack of replication (of autism-candidate genes) [For critiques of
research utilizing twin and family studies, and on the genetic basis of psychiatric disorders,
including autism, see Joseph, 2006, Ch. 7. on Autism]. Other etiological theories that are
common yet remain unsupported, refuted, or unsettled include exposure to childhood
vaccinations and mercury poisoning (Gerber & Offit, 2009; Wright, Pearce, Allgar, Miles,
Whitton, Leon, Jardine, McCaffrey, Smith, Holbrook, Lewis, Goodall, & Alderson-Day, 2012;
Geirer et al., 2008; Mrozek-Budzyn, Kieltyka, & Majewska, 2010; Roehr, 2013). Given the
disorder’s unknown etiology, the road towards treating it remains equally varied and unclear.
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Treatments have ranged across the spectrum, from applied behavior analysis (ABA)
(Rosenwasser & Axelrod, 2001) to dietary interventions such as a gluten-free/casein-free
regimen (Elder, Shankar, Shuster, Theriaque, Burns, & Sherrill 2006), and the use of
antipsychotics such as risperidone (Purdon, Lit, LaBelle, & Jones, 1994). New and novel
treatments are continuously proposed, including hyperbaric oxygen therapy (HBOT).
Hyperbaric oxygen therapy is a treatment in which the patient breathes up to 100%
oxygen in a pressurized environment. It is theorized that HBOT works by increasing atmospheric
pressure, promoting the oxygenation of the blood via breathing this oxygen-enriched air, and
thus blood flow and oxygenation in the brain is enhanced (Sharkey, 2000). Typically, treatments
involve pressurization between 1.5 and 3.0 atmospheres absolute (ATA) for periods between 60
and 120 minutes, once or twice daily. However, there have been no clear HBOT treatment
guidelines for autism.
Since finding success in treating decompression illness (Yarbough & Behnke, 1939),
clinicians have proposed that HBOT could be a viable treatment for a wide variety of issues,
including burns (Bilic et al., 2005), spinal cord injury (Asamoto, Suigiyama, Doi, Iida, Nagao, &
Matsumoto, 2000), and other medical disorders (Gill & Bell, 2004). Rossignol and Rossignol
(2006), two of the most active promoters of HBOT as a treatment for ASD, have suggested that
autism is a neurodegenerative disorder, characterized by a lack of cerebral blood flow,
neuroinflammation, and increased oxidative stress. They offered the following hypothesis on
how hyperbaric therapy may alleviate some of the symptoms of autism:
“HBOT helps overcome hypoperfusion, has potent anti-inflammatory effects and
reduces oxidative stress. Furthermore, HBOT mobilizes stem cells from human bone
marrow. Therefore, HBOT will improve symptoms of autism” (p. 217).
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This view was supported by James Neubrander in his 2007 speech (Neubrander, 2007a) at the
conference of the United States Autism and Asperger Association (USAAA), stating that “the
following…irrefutably demonstrates from collective observations of over 250,000 treatment
hours by my colleagues and me that hyperbaric oxygen therapy is a valuable treatment option for
children with autism” (p. 1, emphasis added). He has also stated that in his clinic, "two of the
most powerful treatments now commonly used for children on the autistic spectrum were
discovered by accident - methylcobalamin (methyl-B12) and hyperbaric oxygen therapy. My
presentation focuses on the use of oxygen under pressure as a powerful treatment modality for
children on the spectrum...In my practice, approximately 80% of children respond to HBOT to
some degree, especially if they continue their treatments....I have found that HBOT is a
treatment, not a cure and continued treatment sets of sessions actually build upon any previous
treatment sets of sessions therefore providing a cumulative beneficial effect...” (Neubrander,
2007b, p. 2).
Here is how one father of a boy treated with HBOT described the treatment, in a
newspaper article:

"HBOT's success is not only the ability to deliver more oxygen, but also to do so under
pressure. More oxygen without the pressure, the body simply can't absorb it. That's
because red blood cells, which transport oxygen throughout the body, are already doing
so at capacity. Pressurization enables the blood plasma, which makes up more than half
of blood, to deliver additional oxygen. For an autistic child, HBOT reactivates blood
vessels in the brain that have ceased functioning and reduces brain inflammation. ...The
Vitaeris 320...allows parent and child to enter the chamber together. Since it is a mild
oxygen-enriched environment, a parent and child can go into the chamber for 1.5 to 2
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hours. Once under pressure they are stuck there until someone else turns off the machine
and the pressure inside the HBOT is reduced to the pressure outside. Exiting the chamber
prematurely puts the person at risk of rupturing his or her eardrums. It takes oxygen from
the surrounding air, compresses it, and pumps it into the chamber where a mask can
direct the oxygen to the child. There is a wireless alarm bell inside that allows a parent to
signal to end the dive session. The user can bring toys and water inside. A viewing port
allows a two-way visual communication (Grundvig, 2007, p. 1).

Each treatment session is said to cost between $250 and $1000. The claims that the brains
of autistic youth suffer from a lack of oxygen is merely a hypothesis and thus far there is no
evidence to support it. The optimistic view of HBOT as a treatment for ASD is not shared by all
hyperbarists. Some researchers (Yildiz, Aktas, & Uzun, 2008; Kot & Mathieu, 2011) are calling
for more empirical evidence of HBOTs effectiveness, before establishing it as a viable treatment
for ASDs. This is a necessary step before professional healthcare workers can ethically
recommend HBOT as a treatment option for ASD. Fortunately, over the past decade, research on
HBOT as a treatment for autism has grown, with some researchers calling for its widespread use.
We conducted the following review evaluating and synthesizing the results of all the available
outcome studies published in English, in peer-reviewed journals, in order to help answer the
question: is hyperbaric oxygen therapy an effective treatment for autism?

Method
Electronic searches were used to identify relevant studies. Searches were made using the
following bibliographic databases: PubMed, ASSIA: Applied Social Sciences Index and
Abstracts, CINAHL, Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane
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Database of Systematic Reviews, PsycINFO, Social Services Abstracts, Database of Randomized
Controlled Trials in Hyperbaric Medicine. Key words used in searching were: Hyperbaric
Oxygen Therapy, Oxygen Therapy, HBOT, Hyperbaric Oxygenation, or Atmospheric Pressure
AND Autism or Autism Spectrum Disorder. Located studies were initially screened based on
their title and abstract. Studies were included if they met all of the following criteria: (a) a singlesystem, pre-experimental, quasi-experimental, or experimental design was used to evaluate
outcomes, (b) the study arrived at an autism or ASD diagnosis based on the DSM-III, DSM-IV.
DSM-IV-TR, Autism Diagnostic Observation Scale (ADOS), Autism Diagnosis Interview
(ADI), Autism Diagnostic Interview-Revised (ADI-R), or other standardized instrument that
assess Autism or ASD symptomology, and have no other severe clinical disorder (e.g. Fragile X
syndrome, cerebral palsy) or have suffered traumatic brain injury, (c) the study used hyperbaric
oxygen therapy as a treatment for symptoms of autism or ASDs, (d) the study reported empirical
outcome measures on any of three behavioral domains (social interaction, communication,
behavior), (e) the study was published in English, and (f) the study was published in a peerreviewed journal. Studies were excluded if they did not report outcomes of treatment or provided
only narrative or case reports. A search of the grey literature (conference papers, unpublished
works, etc.) was not conducted. Hand searches were not performed, nor were attempts made to
contact subject experts. Reference lists were searched for additional studies, but no studies
meeting criteria were identified that had not been previously revealed through electronic
searches. There were no year filters used during searches.
Based on this approach, 39 studies were initially identified. After removing 8 duplicates,
31 records were screened, applying the previously specified inclusion criteria. This resulted in
the exclusion of 23 studies because they reported case reports or were not empirical studies. The
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full-text of the 8 remaining articles was closely examined. All 8 studies are included in this
review, consisting of three randomized-controlled trials (RCTs), one quasi-experimental study,
two pre-experimental evaluations, and two single-system designs. A flow chart depicting the
literature search process is displayed in Figure 1.
Figure 1. Flow Chart Depicting the Literature Search Process.

Records identified through
database searching
(n = 39)

Additional records identified
through other sources
(n = 0)

Records after duplicates removed
(n = 31)

Records screened
(n = 31)

Records excluded
(n = 23)

Full-text articles assessed
for eligibility
(n = 8)

Full-text articles excluded,
with reasons
(n = 0)

Studies included in
qualitative synthesis
(n = 8)
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Results
Study Characteristics:
The studies reviewed included Rossignol et al. (2007), Chungpaibulpatana,
Sumpatanarax, Thadakul, Chantharatreerat, Konkaew and Aroonlimsa (2008), Lerman,
Sansbury, Hovanetz, Wolever, Garcia, O’Brien and Adedipe (2008), Granpeesheh, Tarbox,
Dixon, Wilke, Allen and Bradstreet (2010), Rossignol et al. (2009), Bent, Bertoglio, Ashwood,,
Nemeth, and Hendren (2012), Jepson et al. (2011) and Sampanthavivat, Singkhwa, Chaiyakul,
Karoonyawanich and Ajpru, (2012). An overview of study characteristics is presented in Table 1.
Table 1: Features of Reviewed Studies
Experimental and Quasi-Experimental Designs
Study
Sampanthav
-ivat et al.
(2012)

Intervention
Real (n = 28)
versus Sham
(n = 28)
HBOT

Granpeesheh
et al. (2008)

HBOTa
(n=16) vs.
sham
placebo
(n=18)

Published by UTC Scholar, 2014

Study Population
Children aged 39 years,
diagnosed with
Autism

Study Design
R O-X-O
R O-X-O

Outcomes
ATEC, CGI.
CGIS

Results
Both groups
improved equally,
leading to the
conclusion that
HBOT is a
placebo-based
treatment.

Children ages 214 w/Autistic
Disorder.

R O-X-O
R O-X-O

ABC, BRIEF,
CGI, PSI,
PPVT-III,
RBS, SRS,
VABS-II,
VMI-5, &
direct
observation.

Nine participants
saw improvement
on ADOS
classifications in
both groups. No
significant
differences in
scores were
reported on any
other outcome
measures. Both
groups improved
the same degree
over time.
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Rossignol et
al. (2009)

Intervention
HBOTa
(n=33) vs.
sham
placebo
(n=29)

Rossignol et
al. (2007)

HBOTa
(n=12) vs.
HBOTb
(n=6)

a-24% oxygen at 1.3 ATA

10

Study Population
Children ages 27 w/Autistic
Disorder.

Study Design
R O-X-O
R O-X-O

Outcomes
ABC, ATEC,
CGI

Results
Significant
improvement
within the
hyperbaric group
was observed
across the domains
of overall
functioning,
receptive language,
social interaction,
eye contact, and
sensory/cognitive
awareness,
compared to
participants in the
control condition.

Children ages 316 w/Autistic
Disorder.

O-X-O-O-O-O-O
O-X-O-O-O-O-O

ABC-C, SRS,
and ATEC

Improvements seen
in both groups,
across measures for
irritability, social
withdrawal,
hyperactivity,
motivation, speech,
and
sensory/cognitive
awareness

b-100% oxygen at 1.5ATA

c-100% oxygen at 1.3 ATA

d-88% oxygen at 1.3 ATA

Pre-Experimental Designs
Study
Bent et al.
(2011)

Intervention
Study Population
HBOTb (n=10)
Children
ages 3-8
w/ASD.

https://scholar.utc.edu/jafh/vol6/iss1/5

Study Design
O-X-O-X-O

Outcomes
ABC, PDD-BI,
PIA-CV,
PPVT, SB-V,
and SB-NW

Results
Symptom
improvement was
seen in areas of the
CGI-I, ABC, PDDBI,
PIA-CV, PPVT. The
Stanford-Binet
however, did not
corroborate these
findings, showing no
changes in nonverbal or verbal
intelligence.
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Chungpaibulpa
tana et al.
(2008)

Intervention
Study Population
HBOTc (n=7)
Children
ages 5-9
w/ASD or
Autistic
Disorder.

a-24% oxygen at 1.3 ATA

b-100% oxygen at 1.5ATA

Study Design
O-X-O

c-100% oxygen at 1.3 ATA

Outcomes
*Social
development,
Fine motor and
hand-eye
coordination,
Language
development,
Gross-motor
development,
Self-help skills

11

Results
Improvements
reported in 75% of
participants. 25% of
participants showed
no improvement.
33.34% of children
showed improved
sleeping habits,
improvement in
cognitive abilities,
improved social
skills, and increased
flexibility in terms of
problem solving.
Parents corroborated
these gains.

d-88% oxygen at 1.3 ATA

*- did not disclose instruments used in assessing behavioral domains.
Single-System Designs
Study
Lerman et
al. (2008)

Intervention
HBOTd (n=3)

Study Population
3 children, ages
6-7 w/ Autism.

Study Design
Outcomes
A-B-A
Task
engagement,
spontaneous
communication,
problematic
behavior

Results
HBOT did not improve
task engagement or
decrease problematic
behavior. Data on
spontaneous
communication showed
improvement for one
participant, but overall,
no robust changes were
found.

Jepson
(2011)

HBOTa (n=16)

Children ages 310 w/ Autistic
Disorder, PDD
NOS, Asperger
syndrome.

A-B-A-AA

No consistent effect
across any class of
behavior was seen, nor
was there a clear
change seen for any
individual behavior.

a-24% oxygen at 1.3 ATA

Published by UTC Scholar, 2014

b-100% oxygen at 1.5ATA

ABC-C, SRS,
ATEC, ADOS,
BRIEF, CGI,
PSI, PPVT-III,
RBS, VABS-II,
VMI-5, the
Expressive
Vocabulary Test,
PDDBI, and SB5

c-100% oxygen at 1.3 ATA

d-88% oxygen at 1.3 ATA
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Various assessment measures were used to measure both patient functioning and
outcomes across several domains. While some studies reported biological measures, only
behavioral instruments and measurements will be presented in this review, given that the
diagnosis of autism is arrived at solely by reviewing behavioral indicators. Behavioral measures
included the Aberrant Behavior Checklist-Community (ABC-C), the Social Responsiveness
Scale (SRS), the Autism Treatment Evaluation Checklist (ATEC), the Autism Diagnostic
Observation Schedule (ADOS), the Behavior Rating Inventory of Executive Functioning
(BRIEF), the Clinical Global Impression Scale (CGI), the Parent Stress Index (PSI), Peabody
Picture Vocabulary Rest (PPVT-III), the Repetitive Behavior Scale (RBS), the Vineland
Adaptive Behavior Scales-Second Edition (VABS-II), the Beery-Buktenica Developmental Test
of Visual-Motor Integration-5th Edition (VMI-5), the Expressive Vocabulary Test, the Pervasive
Developmental Disorder Behavior Inventory (PDDBI), and the Stanford-Benet-IV IQ test.
One study (Lerman et al., 2008) directly observed and recorded behaviour across three
primary domains: task engagement, spontaneous communication, and problem behavior. These
domains were operationally defined before assessment of the intervention’s possible effects.
Chungpaibulpatana, Sumpatanarax, Thadakul, Chantharatreerat, Konkaew, & Aroonlimsa (2008)
also reported pre- and post-test measures of social development, fine motor and eye-hand
coordination, language development, gross motor development, and self-help skills, but did not
report the measures used.
Study Outcomes:
Randomized-Controlled Trials
Granpeesheh et al. (2010). The Granpeesheh et al. (2010) study included 34 youth (ages
2-14) diagnosed with Autistic Disorder using DSM-IV criteria and corroborated with the ADOS.
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These participants were recruited from a large community-based agency, which provided
behavioral intervention services for children with ASDs. Originally, 46 children were recruited,
but 12 were subsequently withdrawn from the study by their caregivers. The main reason for
withdrawal was due to travel requirements for treatment. One of the 12 participants withdrew
from the placebo group after having a seizure.
The 34 remaining participants were initially matched in pairs based on the amount of
hours of behaviour-analytic treatment they had received up to the beginning of the study. These
pairs were also matched based on age. Through use of a coin toss, pairs were randomly assigned
to one of two groups, genuine hyperbaric oxygen therapy (n = 18) or placebo HBOT (n = 16).
Both the hyperbaric therapy and the placebo consisted of 80 1-hour sessions in a HBOT
chamber. Participants were to complete the 80 sessions within 15 weeks or less, with a range of
6-10 sessions in the hyperbaric chamber per week. The difference between the two conditions
was that the HBOT group received 24% oxygen at 1.3 ATA, while the placebo group received
free airflow through the chamber at ambient pressure. Investigators, assessors, and the patients’
caregivers were blind to the clients' treatment condition.
Outcome measures included the ABC, BRIEF, CGI, PSI, PPVT-III, RBS, SRS, VABS-II,
and VMI-5. The ASOD, BRIEF, PPVT-III, SRS, VABS, and VMI-5 were administered pre and
post-treatment, while the ABC, CGI, and RBS were administered weekly. The PSI was
administered four times, once at baseline, twice during the treatment phase, and once at the
completion of the study. The authors also utilized direct observation, twice weekly, using
standard functional analysis of “Toy Play.” Trained observers collected data on toy play,
hyperactivity, appropriate vocalizations, vocal stereotypy, physical stereotypy, and challenging
behaviors. Observers were blind to assignment, and observational assessments were subject to
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interobserver agreement (IOA) in at least 30% of observations for each participant. Mean
agreement among observers was 80% or higher for each participant.
Both groups improved over time, but there were no differences in the degree of
improvement between conditions, leading the authors to conclude that HBOT had no genuine
therapeutic effect. This study strongly illustrates the need to compare the results obtained via real
HBOT to a credible placebo treatment, preferably a blinded sham HBOT condition. Solely
examining the results of patients treated with real HBOT may give the appearance of
improvement attributable to the treatment, and give both clinicians and family members
observing these “improvements” a false sense of therapeutic benefit. Thus uncontrolled studies
may be virtually useless in determining the real effects of HBOT above and beyond placebo
factors.
Rossignol et al. (2009). This Rossignol et al. study initially consisted of 62 participants
(ages 2-7) who met DSM-IV criteria for autism, which was corroborated by the ADI-R and
ADOS. Potential participants were excluded if they had met the criteria for Pervasive
Developmental Disorder - Not Otherwise Specified (PDD-NOS), asperger syndrome, seizure
disorder, current ear infection, uncontrolled asthma, Fragile X syndrome, had trouble equalizing
ear pressure, or were receiving ongoing treatment using chelation therapy.
The 62 children were randomly assigned to one of two groups, HBOT (33 children) or
“near-placebo” hyperbaric conditions (29 children). Both conditions provided 40 1-hour
treatment sessions, twice daily, with a minimum of 4 hours between treatments. This was done
for 5 days a week, for 4 consecutive weeks, totalling 40 treatments per participant. Hyperbaric
treatment involved breathing 24% oxygen at 1.3 ATA. The placebo control condition involved
breathing 21% oxygen at 1.03 ATA (e.g. near normal air). Four children in the HBOT group
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dropped out of treatment, whereas three children dropped out of the control group. Of the HBOT
dropouts, two were due to illness, one due to parental and child anxiety, and one due to
worsening asthma symptoms. In the control condition, one child dropped out due to a family
death, another due to travel commitments, and one due to parental claustrophobia. 29 children
completed the study in the hyperbaric condition and 26 in the sham HBOT condition. Allocation
was concealed to everyone involved (investigators, participants, parents, clinic staff, nursing
staff, etc.), with the exception of the hyperbaric technician.
Outcome measures assessed change from baseline to post-treatment. The ABC, ATEC,
and CGI scales were rated by parents or guardians and separately by the treating physician.
Significant improvement within the hyperbaric group was observed across the domains of overall
functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness,
compared to participants in the placebo control condition. These positive results have been
criticized by other researchers in the field. Bent et al. (2012) noted that while this study reported
improvement on the CGI-I for participants in the hyperbaric condition, improvements in other
outcome measures, such as the ABC scale, were not reported. Jepson et al. (2010) point out that
statistically significant outcomes were found in the sensory/cognitive subscale of the ATEC, but
not others. Likewise, it is pointed out that the ATEC has not been validated by the scientific
community for use in this type of study. The Rossignol et al. (2009) study was also criticized for
not collecting pre-treatment reports of the CGI, which prohibits pre-post effect ratings. Also,
physicians did not complete the entire CGI, instead focusing on only one item of the instrument
Sampanthavivat et al. (2012) randomly assigned 60 Thai children with a diagnosis of
Autism to 20 one-hour sessions of HBOT. The children were aged 3-9 years. The experimental
group received 1.5 ATA with 100% oxygen for 20 one-hour sessions conducted over weekdays.
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The placebo control group received sham HBOT, experiencing exactly the same procedures as
did the experimental group, except they breathed a normal air mixture maintained at 1.15 ATA, a
level of air pressure needed to keep the door to the chamber tightly closed and to convey
sensations of increased pressure. Children were accompanied by a parent or other caregiver
during their HBOT sessions. The primary outcome measures were the Autism Treatment
Evaluation Checklist, and the Clinical Global Impression scale, given one-time pre and postHBOT. Patients and their families did not know which treatment they were receiving, real HBOT
or sham HBOT, and neither did the assessors. Thus the study was a double-blind trial. Initial
outcome measure scores did not differ between the two groups pre-treatment. Post-treatment, the
real HBOT group demonstrated statistically significant improvements on the outcome measures,
but these were matched by similar improvements among the parents whose children received
sham HBOT. The authors concluded that "HBOT conferred no benefit above that owing to a
participation (or placebo) effect...Considerably more evidence is needed before accepting there is
a true rationale to support the routine use of low-pressure hyperbaric treatment in order to
improve behavior in children with autism...we cannot recommend the routine use of HBOT in
this regard" (Sampanthavivat et al. 2013, p. 131, 131, 132).

Quasi-Experimental Designs
Rossignol et al. (2007). This study consisted of 18 participants (ages 3-16) diagnosed
with autism by an independent mental health professional. Two groups of children were formed
from the four girls and fourteen boys, using nonrandomized methods. One group (N = 12), 1 girl)
received HBOT at 1.3 ATA and 24% oxygen, while the other group (N = 6, 3 girls) received
HBOT at 1.5 ATA and 100% oxygen (e.g., two different forms of 'real' HBOT). Both groups
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were given HBOT for 45 minutes a session, for 40 treatments per child. The group receiving
24% oxygen averaged 4.6 sessions per week over a 9-week period and the group receiving 100%
oxygen averaged 4.7 treatments over an 8.8-week period. All 18 children were able to complete
the 40 hyperbaric sessions.
Behavioral outcome measures included pre-treatment and post-treatment scores of the
ABC-C, SRS, and ATEC. Parents or guardians, who were not blinded, filled out each scale prior
to treatment, and after 10, 20, 30, and 40 treatment sessions. The authors reported improvements
in both groups, across measures for irritability, social withdrawal, hyperactivity, motivation,
speech, and sensory/cognitive awareness. The authors note, however, that this data is limited by
a lack of assessor blinding, a lack of placebo or control group, non-random assignment to
conditions, and the possibility that chance or natural development of the children influenced the
outcomes.
Pre-Experimental Designs
Bent et al. (2012). This Bent et al. study examined the effects of HBOT on one group of
10 children, recruited from an outpatient autism clinic. The children ranged in age from 3 to 8
years, and had a DSM-IV diagnosis of ASD, corroborated by the ADOS and the SCW.
Treatment consisted of all participants receiving HBOT at 1.5 ATA and 100% oxygen.
Participants received a total of 80 treatment sessions over the course of 20 weeks. 40 treatment
sessions were given over the course of 8 weeks, followed by a 4-week break, followed by
another 40 treatment sessions over an 8 week period. Children were assessed pre-treatment, after
40 days, and after 80 days of treatment. Outcome measures used included the ABC, PDD-BI,
PIA-CV, PPVT, SB-V, and SB-NW. Guardians completed the ABC and PDDBI. Clinicians
rated and scored the CGI-I, based on parent interviews and direct clinical observation. The
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authors reported marked improvement in symptoms for parent-reported measures. Symptom
improvement was seen in areas of the CGI-I related to imitation, eye contact, language, eczema,
gastrointestinal problems, and severity/frequency of tantrums. Scores on the ABC showed
improvement in irritability, lethargy, hyperactivity, and total score. The PDDBI showed
statistically significant improvements across three of ten subscales. The PIA-CV showed
improvement in terms of language, intelligence, while the PPVT showed improvement in
receptive vocabulary. The Stanford-Binet however, did not corroborate these findings, showing
no changes in non-verbal or verbal intelligence. The authors caution that these outcomes relied
heavily on parent reported measures, and that reporting may be influenced by parental bias or the
placebo effect. Due to the small sample size, weak methodology (being a one group, pre-test
post-test design lacking any comparison groups), and reliance on parent reported outcomes, it is
not possible to definitively say whether HBOT was responsible for any improvements reported at
the conclusion of treatment.
Chungpaibulpatana et al. (2008). This study examined the effects of HBOT on seven
Thai children (ages 5-9) who had a DSM diagnosis of ASD or Autistic Disorder. Treatment
involved HBOT at 1.3ATA and 100% oxygen given once a week for 10 weeks. Assessment
measures were taken pre and post-treatment.
The study measured changes across five domains: 1) Social development, 2) Fine motor
and hand-eye coordination, 3) Language development, 4) Gross-motor development, and 5) Selfhelp skills. Scales used in assessment were not disclosed. The authors reported statistically
significant improvements across all five domains with 75% of participants having positive
outcomes and 25% not improving. 33.34% of children showed improved sleeping habits,
improvement in cognitive abilities, improved social skills, and increased flexibility in terms of
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problem solving. These gains were corroborated by parents, but the findings are limited in
several ways. First, the study lacked a comparison or no-treatment group, which prevents the
authors from concluding that HBOT was responsible for the changes witnessed in the children.
Second, subjective responses from children and parents may have been influenced by the placebo
effect or by reporting bias. Lastly, the clinical significance of the data cannot be determined due
to the study’s small sample size and the authors' limited description of outcome measures.
Single-System Designs
Lerman et al. (2008). This study examined the effects of HBOT given to three children
diagnosed with Autism. The participants were two 6-year-old boys and one 7-year-old girl.
HBOT was given in 60-minute sessions, for a total of 40 sessions, at 88% oxygen and 1.3 ATA.
Ultimately, the two boys completed 40 sessions of treatment and the girl completed 27 sessions
before stopping due to the development of an unrelated eye infection.
A non-concurrent multiple-baseline design across participants was utilized for the study.
The first participant was measured at baseline for a minimum of 20 days before treatment. The
second participant received treatment after 40 days of baseline and the third received treatment
after 60 days.
Participants were videotaped three times a week, during 10-minute instructional session
given at the center. Data software was utilized to score child and therapist responses, by
observers who were blind to the study’s purpose and to the timing of the intervention.
Participant behavior was measured in terms of the frequency of unprompted task engagement
and the frequency of spontaneous communication and problem behavior. The results suggest that
HBOT did not improve task engagement or decrease problematic behavior. Data on spontaneous
communication was inconclusive (with one participant showing improvement for this measure),
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but overall, no clinically meaningful behavioral improvements were found. A strength of this
study is that detailed and reliable measures of the children's functioning were repeatedly assessed
before and after the use of HBOT. To the extent that HBOT is claimed to yield improvements in
behavior among youth with autism, this hypothesis was falsified in this intensive study.
Jepson et al. (2011). This study directly observed the behaviors of 16 children (ages 310) diagnosed with Autistic Disorder, PDD NOS, or Asperger’s syndrome. Participants were
assessed prior to treatment using the ADOS, the Wechsler Preschool and Primary Intelligence-III
or the Wechsler Abbreviated Scale of Intelligence, the Vineland Adaptive Behavior Scale-II, and
the ABC.
This study used a non-concurrent multiple-baseline design, across participants. Treatment
consisted of 40 sessions of HBOT at 24% oxygen and 1.3 ATA, for 60 minutes, conducted over
an average of 8 weeks. Participants were followed up at 2 weeks after the last HBOT session and
at the 3-month mark, for observational play sessions. These sessions were used to gather data
across 11 operationally defined behaviors.
The behavioral observations results were recorded in three classes: 1) adaptive behavior
(vocal initiations, physical initiations, vocal response, and physical response), 2) stereotypy
(vocal and physical stereotypy), and 3) aberrant behavior (rate of aggression, self-injurious
behavior, tantrums, and disruption). The authors concluded: "Multiple topographies of behavior
were measured under carefully controlled conditions and no consistent effects (positive or
negative) were observed. Based on these results, there is no compelling evidence to suggest that
HBOT, delivered at 24% oxygen and 1.3 ATA, is an effective treatment modality for the core
behavior symptoms of Autism" (Jepson et al., 2011, p. 583).
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Discussion
Of the eight studies included in this review, four (Granpeesheh et al., 2010; Bent et al.,
2012; Lerman et al., 2008; Jepson et al., 2011) suggested that HBOT might not be an effective
treatment for the behavioral symptoms of Autism and ASDs. The remaining three studies
(Rossignol et al., 2009; Rossignol et al., 2007; Chungpaibulpa et al., 2008) suggested that HBOT
might help decrease some behavioral symptoms associated with Autism and ASDS. The data
gathered from these eight studies is limited by small sample sizes (214 total participants), a lack
of rigorous study designs, a reliance on parent-rated assessments, and a lack of comparison,
placebo, and no-treatment groups. These limitations could be remedied through the use of a
large, multi-armed, double-blinded randomized control trial that compares different types of
hyperbaric treatment with placebo and no treatment conditions. While this has been attempted by
Granpeesheh et al. and Rossignol et al. (2009), several issues have risen. Granpeesheh et al. were
lacking a no-treatment group and relied heavily on parent-rated assessments, which left open the
possibility of parental bias. The Rossignol study also relied heavily on these assessments and
has been criticized by other hyperbaric researchers (Bent et al.; Jepson et al.) for faulty data
interpretation and usage.
It remains to be seen if hyperbaric therapy can alleviate some of the symptoms of autism.
The three strongest designs to date, Lerman et al., (2008), Jepson et al. (2011) and
Sampanthavivat et al. (2013), suggest that it does not. The current evidence reviewed does not
support hyperbaric oxygen therapy as an effective treatment for autism or Autism Spectrum
Disorders. Clinicians have the responsibility to offer safe as well as empirically supported
treatments. Currently, it is premature to call HBOT an efficacious treatment and the available
evidence suggests that the limited positive changes following its application are most
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parsimoniously explained as placebo effects. Support of more rigorous trials, especially largescale RCTs, with valid control and comparison groups, and proper blinding and assessment tools,
are required before HBOT can be recommended as an option for those with autism and ASD.
Persons who receive HBOT as a clinical treatment, outside of the context of a well-designed
RCT, should have the effects of their therapy carefully evaluated using an experimental single
subject research design.
We note the principles enunciated in the American Medical Association's Code of Ethics,
reading:
"The following general guidelines are offered to serve physicians when they are called upon
to decide among treatments:

(1) Treatments which have no medical indication and offer no possible benefit to the patient
should not be used.

(2) Treatments which have been determined scientifically to be invalid should not be used

(4) Among the various treatments that are scientifically valid, medically indicated, legal, and
offer a reasonable chance of benefit for patients, the decision of which treatment to use should be
made between the physician and patient." (American Medical Association's Code of Ethics,
downloaded from http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/codemedical-ethics.page? on 27 March 2013, emphases added)

Individuals and families seeking accurate and up-to-date information about the scientific
status of various therapies for autism may consult a summary of the evidence on these treatments
to be found at http://www.asatonline.org/treatment/treatments_desc, a website maintained by the
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Association for Science in Autism Treatment, as well as Offit (2010) and Thyer & Pignotti
(2010). Until better evidence accrues through carefully controlled evaluations, individuals with
Autistic Spectrum Disorders should not be subjected to expensive sessions of HBOT.
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